Submitted by Anonymous (not verified) on 31 August 2023 - 11:17
Human medicines European public assessment report (EPAR): Adempas, riociguat, Hypertension, Pulmonary, Date of authorisation: 27/03/2014, Revision: 13, Status: Authorised
Source: